Squarepoint Ops LLC Ngm Biopharmaceuticals Inc Transaction History

Squarepoint Ops LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.6 - $1.31 $127,749 - $278,919	212,916 New	212,916 $183,000
Q1 2023 May 15, 2023	SELL	$3.72 - $5.4 $101,645 - $147,549	-27,324 Reduced 27.67%	71,443 $291,000
Q4 2022 Feb 14, 2023	BUY	$3.41 - $12.93 $248,428 - $941,989	72,853 Added 281.13%	98,767 $495,000
Q3 2022 Nov 14, 2022	BUY	$12.59 - $17.67 $326,257 - $457,900	25,914 New	25,914 $339,000
Q2 2022 Aug 15, 2022	SELL	$10.58 - $17.5 $409,943 - $678,072	-38,747 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$13.81 - $18.6 $393,322 - $529,746	28,481 Added 277.43%	38,747 $591,000
Q4 2021 Feb 14, 2022	SELL	$17.26 - $22.02 $100,280 - $127,936	-5,810 Reduced 36.14%	10,266 $182,000
Q3 2021 Nov 15, 2021	SELL	$20.15 - $26.19 $125,332 - $162,901	-6,220 Reduced 27.9%	16,076 $338,000
Q2 2021 Aug 16, 2021	SELL	$15.06 - $30.03 $26,249 - $52,342	-1,743 Reduced 7.25%	22,296 $440,000
Q1 2021 May 17, 2021	BUY	$24.99 - $31.93 $85,490 - $109,232	3,421 Added 16.59%	24,039 $699,000
Q4 2020 Feb 16, 2021	BUY	$16.21 - $31.44 $334,217 - $648,229	20,618 New	20,618 $625,000
Q3 2020 Nov 16, 2020	SELL	$15.59 - $19.97 $460,294 - $589,614	-29,525 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$11.97 - $23.47 $353,414 - $692,951	29,525 New	29,525 $583,000

2.6M

300

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.